| Strides Pharma Science Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532531 |
NSE Symbol : STAR |
P/E(TTM) : 43.66 |
|
ISIN Demat : INE939A01011 |
Div & Yield% : 0.46 |
EPS(TTM) : 19.90 |
|
Book Value(₹) : 344.58 |
Market Cap(₹Cr) : 8,007.97 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 553.63 | 522.15 | 498.62 | 555.96 | 550.92 | 519.55 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 553.63 | 522.15 | 498.62 | 555.96 | 550.92 | 519.55 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 103.24 | 14.09 | 1.76 | 12.12 | 2.43 | 23.55 |
| Total Income | 656.88 | 536.24 | 500.37 | 568.08 | 553.35 | 543.10 |
| Total Expenditure | 472.43 | 459.93 | 431.39 | 488.03 | 476.84 | 464.19 |
| PBIDT | 184.44 | 76.32 | 68.99 | 80.05 | 76.51 | 78.90 |
| Interest | 27.25 | 29.41 | 30.45 | 29.36 | 34.21 | 41.83 |
| PBDT | 157.20 | 46.90 | 38.54 | 50.69 | 42.29 | 37.08 |
| Depreciation | 22.40 | 21.51 | 22.14 | 22.37 | 20.92 | 20.70 |
| Tax | 22.78 | -11.37 | -0.05 | -5.24 | 5.74 | -3.02 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -9.87 | 4.72 | 3.10 | 17.43 | 0.70 | 2.15 |
| Reported Profit After Tax | 121.90 | 32.04 | 13.35 | 16.13 | 14.94 | 17.26 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Adjusted Profit After Extra-ordinary item | 121.90 | 32.04 | 13.35 | 16.13 | 14.95 | 17.27 |
| EPS (Unit Curr.) | 13.22 | 3.48 | 1.45 | 1.75 | 1.62 | 1.88 |
| EPS (Adj) (Unit Curr.) | 13.22 | 3.48 | 1.45 | 1.75 | 1.62 | 0.82 |
| Calculated EPS (Unit Curr.) | 13.22 | 3.48 | 1.45 | 1.75 | 1.62 | 1.88 |
| Calculated EPS (Adj) (Unit Curr.) | 13.22 | 3.48 | 1.45 | 1.75 | 1.62 | 0.82 |
| Calculated EPS (Ann.) (Unit Curr.) | 52.90 | 13.90 | 5.79 | 7.00 | 6.48 | 7.51 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 52.90 | 13.90 | 5.79 | 7.00 | 6.48 | 3.29 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 92.17 | 92.17 | 92.16 | 92.16 | 92.16 | 91.96 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 33.31 | 14.62 | 13.84 | 14.40 | 13.89 | 15.19 |
| PBDTM(%) | 28.39 | 8.98 | 7.73 | 9.12 | 7.68 | 7.14 |
| PATM(%) | 22.02 | 6.14 | 2.68 | 2.90 | 2.71 | 3.32 |